Bonnie Brae Skilled Nursing | |
420 South Bonnie Brae St., Los Angeles, California 90057 | |
(213) 483-8144 | |
Name | Bonnie Brae Skilled Nursing |
---|---|
Location | 420 South Bonnie Brae St., Los Angeles, California |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 59 |
Occupancy Rate | 71.19% |
Medicare ID (CCN) | 055538 |
Legal Business Name | Bonnie Brae Convalescent Hospital Inc. |
Ownership Type | For Profit - Corporation |
NPI Number | 1487706628 |
Organization Name | BONNIE BRAE CONVALESCENT HOSPITAL INC. |
Address | 420 S Bonnie Brae St, Los Angeles, CA 90057 |
Phone Number | 213-483-8144 |
News Archive
With the decreasing cost and increasing throughput of sequencing, researchers require a high-performance, cost-effective sample preparation pipeline for targeted sequencing. To enable researchers to more readily match targeted sequencing sample preparation throughput to the ever increasing throughput of next-generation sequencing, Roche NimbleGen announces the imminent launch of a pre-capture multiplex target enrichment protocol.
Co-founded back in 2014 by VHIO's Laura Soucek, CEO of the enterprise, and Marie-Eve Beaulieu, Chief Scientific Officer (CSO) of the company, VHIO-born spin-off Peptomyc S.L. has just announced that it has received approval from the Spanish Agency of Medicines and Medical Devices for conducting clinical trials in Spain (AEMPS), to initiate the first-in-human Phase I/II clinical trial with its first compound - a disruptive Myc inhibitor, Omomyc (OMO-103).
Thoughts on neck pain from a Cervical Herniated Disc from Life Care Solutions Group's Sacramento Injury Lawyer, Dr. Greg Vigna.
Offering an ultrasensitive yet accessible approach to COVID-19 testing, a portable saliva-based smartphone platform provides results within 15 minutes without the resource-intensive laboratory tests the current gold standard requires, according to a new study.
Scientists from the Imperial College London and the Imperial College Healthcare NHS Trust, UK, have conducted a cross-sectional, questionnaire-based survey to evaluate the public's willingness to receive coronavirus disease 2019 (COVID-19) vaccination and their attitude toward prioritization.
› Verified 3 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
With the decreasing cost and increasing throughput of sequencing, researchers require a high-performance, cost-effective sample preparation pipeline for targeted sequencing. To enable researchers to more readily match targeted sequencing sample preparation throughput to the ever increasing throughput of next-generation sequencing, Roche NimbleGen announces the imminent launch of a pre-capture multiplex target enrichment protocol.
Co-founded back in 2014 by VHIO's Laura Soucek, CEO of the enterprise, and Marie-Eve Beaulieu, Chief Scientific Officer (CSO) of the company, VHIO-born spin-off Peptomyc S.L. has just announced that it has received approval from the Spanish Agency of Medicines and Medical Devices for conducting clinical trials in Spain (AEMPS), to initiate the first-in-human Phase I/II clinical trial with its first compound - a disruptive Myc inhibitor, Omomyc (OMO-103).
Thoughts on neck pain from a Cervical Herniated Disc from Life Care Solutions Group's Sacramento Injury Lawyer, Dr. Greg Vigna.
Offering an ultrasensitive yet accessible approach to COVID-19 testing, a portable saliva-based smartphone platform provides results within 15 minutes without the resource-intensive laboratory tests the current gold standard requires, according to a new study.
Scientists from the Imperial College London and the Imperial College Healthcare NHS Trust, UK, have conducted a cross-sectional, questionnaire-based survey to evaluate the public's willingness to receive coronavirus disease 2019 (COVID-19) vaccination and their attitude toward prioritization.
› Verified 3 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 10.24 | 14.46 |
Percentage of long-stay residents who lose too much weight | 6.67 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 46.55 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 2.13 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 0 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 6.51 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 1.64 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 97.81 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 28.37 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 50 | 83.88 |